Species Differences in Stereoselective Pharmacokinetics of HSG4112, A New Anti-Obesity Agent by In Yong Bae, Min Sun Choi, Young Seok Ji, Sang-Ku Yoo, Kyungil Kim, Hye Hyun Yoo

Get full text

Preclinical Bioavailability Assessment of a Poorly Water-Soluble Drug, HGR4113, Using a Stable Isotope Tracer by Eun Ji Ha, Jeong In Seo, Shaheed Ur Rehman, Hyung Soon Park, Sang-Ku Yoo, Hye Hyun Yoo

Get full text

Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects by Heejae Won, Deok Yong Yoon, Sangmi Lee, Joo‐Youn Cho, Jaeseong Oh, In‐Jin Jang, Sang‐Ku Yoo, Kyung‐Sang Yu

Get full text

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study by Joo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, SeungHwan Lee, Kyung‐Sang Yu, In‐Jin Jang, Sang‐Ku Yoo, Youngah Kim, Jaeseong Oh

Get full text

Paraoxonase-2 contributes to promoting lipid metabolism and mitochondrial function via autophagy activation by Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Ku Yoo, Hyung Soon Park, Leo Sungwong Choi, Kwang Pyo Kim, Ah-Ra Lee, Sang-Uk Seo, Kyun-Hwan Kim

Get full text